Samjin Pharmaceutical Co., Ltd.

About Samjin Pharmaceutical Co., Ltd.

We, Samjin Pharmaceutical Co., Ltd. are striving to develop a drug for a healthy life and fruitful future as one of the leading companies in Korea. Since our company was founded in 1968, we have been growing up with competitive medical products and a high preference for patients. And also our R&D Center is strengthening its global competitiveness by getting an outstanding pipeline.




...

Certifications
  • KR
  • 2022
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
API Producer
Pharmaceutical Company (generic finished products)
Contact info
  • 121, Wausan-ro, Mapo-gu, 04054, Seoul, Korea, Republic Of

Products from Samjin Pharmaceutical Co., Ltd. (3)

  • Maciten Tablet

    Product Maciten Tablet

    1. Active Ingredient & Strength : Micronized Macitentan 10 mg 2. Indication : Pulmonary arterial hypertension (PAH) 3. Characteristics : - Dual ERA (bosentan + ambrisentan) - Long-term treatment of adult patients with PAH (WHO Group I) corresponding to WHO functional classifications II to III 4. Developm...
  • Apixaban Tablet

    Product Apixaban Tablet

    1. Active Ingredient & Strength : Apixaban 2.5 mg, 5 mg 2. Indication : Non-vitamin K antagonist oral anticoagulant (NOAC) 3. Development Status : BE test completed 4. Dossier : Elemental impurities data available
  • Dapagliflozin propanediol hydrate + Sitagliptin (Tablet)

    Product Dapagliflozin propanediol hydrate + Sitagliptin (Tablet)

    1. Active Ingredient & Strength : Dapagliflozin propanediol hydrate + Sitagliptin 100 mg/10 mg 2. Indication : Diabetes 3. Characteristics : - Simplification of 5GLT + DPP-4 co-administration - Small tablet size 4. Development Status : BE test completed